Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7156 in Healthy Participants
NCT07601087Phase 1Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Jun 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of HRS-7156 in heart failure (HF) (2 arms), sponsored by Shandong Suncadia Medicine Co., Ltd. Primary endpoint: Incidence of adverse event (AE) and serious adverse event (SAE) at 14 days. Started Jun 2026; status: recruiting.
02
Drugs
HRS-7156
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07601087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07601087.